Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
Full story
Read the full story at TechCrunch ↗
Continue reading this story on TechCrunch, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.